Page 2 - Phoebe Mounts News Today : Breaking News, Live Upda

CorMedix Inc Common Stock (CRMD) Q2 2022 Earnings Call Transcript

Published: August 11, 2022

CRMD earnings call for the period ending June 30, 2022.

CorMedix Inc. (CRMD) CEO Joe Todisco on Q1 2022 Results - Earnings Call Transcript

Published: May 13, 2022

CorMedix Inc. (NASDAQ:NASDAQ:CRMD) Q1 2022 Earnings Conference Call May 12, 2022 16:30 ET Company Participants Daniel Ferry - Investor Relations Joe Todisco - Chief Executive Officer Matt...

Source: seekingalpha.com

Robbins Geller Rudman & Dowd LLP Announces that CorMedix

Published: August 28, 2021

SAN DIEGO, Aug. 28, 2021 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of CorMedix Inc. (NASDAQ: CRMD)...

Source: globenewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline

Published: August 20, 2021

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and...

Source: prnewswire.com

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline

Published: July 29, 2021

Share this article Share this article NEW YORK, July 28, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. ("CorMedix" or the "Company") (NASDAQ: CRMD) and certain of its officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed under 21-cv-14020, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired CorMedix securities between July 8, 2020 and May 13, 2021, both dates inclusive (the "Class Period"), seeking ...